Cardiac allograft vascular disease after orthotopic heart transplantation: Methylenetetrahydrofolate reductase gene polymorphism C677T does not account for rapidly progressive forms

Transplantation

Volumn 69, Issue 3, 2000, Pages 442-445

  Pethig, Klaus ^a   Hoffmann, Andrea ^b   Heublein, Bernd ^a   Timke, Adine ^a   Gross, Gerhard ^b   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

EID: 0034002970     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002150-00025     Document Type: Article

References (10)

1. Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily P. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report (1996). J Heart Lung Transplant 1996; 15: 655.
2. Weis M, van Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 1997; 96: 2069.
3. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 27: 1049.
4. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536.
5. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111.
6. Tsai JC, Perella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 6369.
7. Verhoef P, Rimm EB, Hunter DJ, Chen J, Willett WC, Lesey K, Stampfer MJ. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men. J Am Coll Cardiol 1998; 32: 353.
8. Pethig K, Hoffmann A, Borlak J, Oppelt P, Heublein B. Tumor-necrosis-factor polymorphism and development of allograft vascular disease after heart transplantation [Abstract]. Circulation 1998; 97: 751.
9. Ambrosi P, Barlatier A, Habib G, et al. Hyperhomocysteinaemia in heart transplant recipients. Eur Heart J 1994; 15: 1191.
10. Gupta A, Moustapha A, Jacobsen DW, et al. High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients. Transplantation 1998; 65: 544.